Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Rangering i aksjer #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Aksjekurs
$45.64
Sist synkronisert: 2026-08-28
Markedsverdi
$969.02M
Endring (1 dag)
-1.20%
Endring (1 år)
146.66%
Land
KR
Handel Orum Therapeutics, Inc. (475830)

Kategori

Pris 475830 pris med markedsverdi på B
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
475830
$45.64
Markedsverdi av Orum Therapeutics, Inc.(475830)
Markedsverdi: $969.02M
Per August 2026 har Orum Therapeutics, Inc. en markedsverdi på $969.02M. Dette gjør Orum Therapeutics, Inc. til det 9664th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Orum Therapeutics, Inc. fra 2025 til 2026
475830 sammenlignet med topp 5 mest populære stocks
Pris på 475830 Eiendel B Markedsverdi for B Resultater
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$247,917 $969.02M
$5.264T +543,118.35%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$221,420 $969.02M
$4.701T +485,060.24%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$196,736 $969.02M
$4.177T +430,974.59%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$179,792 $969.02M
$3.817T +393,846.51%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$134,998 $969.02M
$2.866T +295,698.99%